Real world study of BTK inhibitors for treatment of Waldenstrom Macroglobulinemia
Home / Resource Library / Efficacy and Safety of Bruton Tyrosine Kinase Inhibitors in Waldenstrom Macroglobulinemia: A Single-Center Retrospective Analysis
Real world study of BTK inhibitors for treatment of Waldenstrom Macroglobulinemia